Note: Ingredients listed on restricted chemical lists
EC/CAS
13674-84-5
Name of the chemical
Tris(2-chloro-1-methylethyl) phosphate
Concentration
1%-20%
EC/CAS
75-28-5
Name of the chemical
iso-Butan, enthält 0,1% Butadien
Concentration
1%-10%
EC/CAS
78-40-0
Name of the chemical
Phosphoric acid, triethyl ester, TEP
Concentration
1%-10%
EC/CAS
101-68-8
Name of the chemical
4,4’-Methylenediphenyl diisocyanate
Concentration
>25%
EC/CAS
9016-87-9
Name of the chemical
4,4'-Methylendiphenyldiisocyanat tech. (Polymeres) MDI, pMDI (in Form atembarer Aerosole, A-Fraktion)
Concentration
>25%
General Information
Revision date
2024-02-23
Product name
SOUDAL Soudabond Subfloor
Product Synonyms
137642
1.2.1 Relevant identified uses
Refer to Technical Information
1.2.2. Uses advised against
Refer to Technical Information
Icons in SDS
Company Information
company name
Soudal
GHS Information
Signal word
Danger
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
CARCINOGENICITY - Category 2 FLAMMABLE AEROSOLS - Category 1 GASES UNDER PRESSURE - Liquefied gas SENSITIZATION - RESPIRATORY - Category 1 SERIOUS EYE DAMAGE /EYE IRRITATION - Category 2A SKIN CORROSION/IRRITATION - Category 3 SPECIFIC TARGET ORGAN TOXICITY (Single Exposure) - Category 3
Signal word
Danger
Hazard statements
Causes mild skin irritation Causes serious eye irritation Contains gas under pressure; may explode if heated Extremely flammable aerosol May cause allergy or asthma symptoms or breathing difficulties if inhaled May cause respiratory irritation; or May cause drowsiness or dizziness Suspected of causing cancer (state route of exposure if no other routes of exposure cause the hazard)
Response
Call a poison center or doctor if you feel unwell. If experiencing respiratory symptoms: Call a poison center/doctor/ ... If exposed or concerned: Get medical advice/attention. If eye irritation persists: Get medical advice/attention. If in eyes: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If inhaled: If breathing is difficult, remove person to fresh air and keep comfortable for breathing. If inhaled: Remove person to fresh air and keep comfortable for breathing. If skin irritation occurs: Get medical advice/attention.
Prevention
Avoid breathing dust/fume/gas/mist/ vapors/spray. Do not handle until all safety precautions have been read and understood. Do not spray on an open flame or other ignition source. In case of inadequate ventilation wear respiratory protection. Keep away from heat. Obtain special instructions before use. Pressurized container: Do not pierce or burn, even after use. Use only outdoors or in a well-ventilated area. Wash thoroughly after handling. Wear eye protection/face protection. Wear protective gloves/protective clothing/eye protection/face protection.
Storage
Protect from sunlight. Do not expose to temperatures exceeding 50 ºC/122 ºF. Protect from sunlight. Store in a well-ventilated place. Store in a well-ventilated place. Keep container tightly closed. Store locked up.
Disposal
Dispose of contents/container to Dispose of contents/container in accordance with local, regional, national and international regulations. Ingredients of unknown toxicity 0%
Other hazards
Persons already sensitized to diisocyanates may develop allergic reactions when using this product. Persons suffering from asthma, eczema or skin problems should avoid contact, including dermal contact, with this product. This product is not to be used under conditions of poor ventilation. Gas/vapor spreads at floor level: Ignition hazard. Section 3. Ingredients CAS Ingredient Name Weight % 13674-84-5 2-Propanol, 1-chloro-, phosphate (3:1) 1% - 20% 25791-96-2 Glyceryl polypropylene glycol triether 1% - 20% 75-28-5 Isobutane 1% - 10% 115-10-6 Dimethyl ether 1% - 10% 74-98-6 Propane 1% - 10% 78-40-0 Triethyl phosphate 1% - 10% 101-68-8 4,4'-Diphenylmethane diisocyanate > 25 % 9016-87-9 Polymeric diphenylmethane diisocyanate > 25 % Occupational exposure limits, if available, are listed in Section 8.